Equities

Linical Co Ltd

2183:TYO

Linical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)400.00
  • Today's Change2.00 / 0.50%
  • Shares traded20.20k
  • 1 Year change-41.86%
  • Beta0.7057
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue12,30812,51711,555
OPERATING EXPENSES
Cost of revenue total8,5308,3557,944
Selling, general and admin. expenses, total2,7052,5862,254
Depreciation/amortization347319272
Unusual expense(income)142(77)140
Other operating expenses, total0.000.000.00
Total operating expense11,72411,18310,609
Operating income5831,334946
Other, net--0.00(1.1)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes6601,3791,032
Provision for income taxes322374241
Net income after taxes3381,004790
Minority interest------
Net income before extra. Items3381,004790
Total extraordinary items------
Net income3381,004790
Inc.avail. to common excl. extra. Items3381,004790
Inc.avail. to common incl. extra. Items3381,004790
EPS RECONCILIATION
Basic/primary weighted average shares232323
Basic/primary eps excl. extra items154435
Basic/primary eps incl. extra items154435
Dilution adjustment------
Diluted weighted average shares232323
Diluted eps excl. extra items154435
Diluted eps incl. extra items154435
COMMON STOCK DIVIDENDS
DPS - common stock primary issue151414
Gross dividend - common stock339316316
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental181314
SUPPLEMENTAL INCOME
Depreciation, supplemental171181169
Total special items490241412
NORMALISED INCOME
Normalized income before taxes1,1501,6201,444
Effect of special items on income taxes69(21)33
Income tax excluding impact of special items391353274
Normalized income after tax7591,2671,169
Normalized income avail. to common7591,2671,169
Basic normalized EPS345652
Diluted normalized EPS345652
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.